Icon

Exalgo - (8,12,16,32 mg; Tablet, Extended Release)

Hydromorphone Hydrochloride Spec Gx
8,12,16,32 mg; Tablet, Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Indications for EXALGO: Management of pain in opioid-tolerant patients severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative therapies are inadequate.
Yes
****** ** *** ***** ** **** **** ** **** ****** '*** ******** ** **** *, **** *** *** ************ ********* ** ************. ****** *** ****** ** **-***** ****, ************ ******* ********** **** ******, ********* ** *** ***** ** ***** ****** *** ****** *** ******* ** *** **, ****.
  1. *** **, **** : ****** ******** ************ ***** *** **** ** ****** *********** ****** ** '***.
  2. *** **, **** : ************ **** ****** **** *** **** ** ****** ** ******** ***** ** *** ******.
  3. *** **, **** : ************ ******* ********** **** ******, ********* ** *** ***** ** ***** ****** *** ****** *** ******* ** *** **, ****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.